Search results
Showing 3646 to 3660 of 8230 results
Membership details, terms of reference, future meeting dates and past meeting minutes for our 4 technology appraisal committees.
Bisphosphonates for treating osteoporosis Patient decision aid What is osteoporosis and how can bisphosphonates help? Everyone's bones get weaker as...
Our resource planner tool to help you plan for and implement NICE guidance.
We estimate the costs or savings (resource impact) associated with technologies and guidelines so you can plan for and implement guidance.
Find out what guidance is being considered for development
This indicator covers the percentage of patients with a new diagnosis of hypertension in the preceding 1 April to 31 March who have a record of a 12-lead ECG performed in the 3 months before or after the date of entry to the hypertension register. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM77
Sedaconda ACD-S for sedation with volatile anaesthetics in intensive care (HTG607)
Evidence-based recommendations on Sedaconda ACD-S for sedation with volatile anaesthetics in intensive care.
Our framework agreement allows UK NHS, health and social care organisations to buy knowledge resources that support practice, learning and development.
Check to see if you're entitled to access a range of content purchased by the NHS. If you are eligible, you can register for an OpenAthens account using our online form.
NHS OpenAthens accounts are managed by a network of administrators who can answer questions and offer support to users in England.
A new model for evaluating and purchasing antimicrobials in the UK
Overview of NICE and NHS England’s pioneering subscription-style purchasing model for antimicrobials: its pilot with ceftazidime-avibactam and cefiderocol in 2022, expansion in 2024, supporting health technology assessments, downloadable guidance and procurement tools.
Find out which guidance and quality standards are awaiting development
See a complete list of all our guidance and quality standards currently open for consultation
Evidence-based recommendations on Alpha-Stim AID for managing anxiety disorders.
Evidence-based recommendations on the ReCell Spray-On Skin system for treating skin loss, scarring and depigmentation after burn injury.